Nausea, vomiting and gut effects of retatrutide

Stomach and bowel effects are the most common side effects of retatrutide by a wide margin. In the trials they were mostly mild to moderate, worst while the dose was being stepped up, and eased over weeks. In a small number of people they were severe enough to cause dehydration, and that is where they become dangerous.

How common were gut effects?

The clearest picture comes from TRIUMPH-1, the largest trial to report so far.

Every gut effect rises with dose, and none of them is rare. On the 12 mg arm, more than four in ten people reported nausea at some point over 80 weeks, and one in four vomited.^[1] The placebo column matters too: one in seven people on dummy injections also reported nausea, so not every queasy day is the drug.

The other trials tell the same story:

• TRIUMPH-2 (type 2 diabetes): diarrhoea 27.4% to 33.6% across the retatrutide arms versus 13.2% on placebo; nausea 13.7% to 28.0% versus 8.0%; constipation 14.0% to 16.8% versus 9.4%.^[4]
• TRIUMPH-3 (severe obesity with heart disease): diarrhoea 24.4% to 30.1% versus 8.7%; nausea 21.7% to 22.4% versus 5.8%; constipation 15.7% to 18.0% versus 7.1%.^[4]
• TRIUMPH-4 (knee osteoarthritis): nausea 38.1% and 43.2% on the two doses versus 10.7%; vomiting 20.4% and 20.9% versus none on placebo; diarrhoea 34.7% and 33.1% versus 13.4%.^[5]
• TRANSCEND-T2D-1 (diabetes, 40 weeks): nausea 16.4% to 26.5% versus 3.7%; diarrhoea 18.7% to 26.3% versus 4.5%; vomiting 15.0% to 17.6% versus 2.2%.^[6]
• Phase 2 (48 weeks): nausea ranged from 14% on the lowest dose to 60% in the highest-dose group that started at the higher of two starting doses. Effects were dose-related and mostly mild to moderate.^[2]

When it happens, and how long it lasts

In the Phase 2 trial, gut symptoms were concentrated in the period when the dose was being stepped up, and most were mild or moderate.^[2] That pattern is shared with the licensed relatives of this drug: the Mounjaro summary of product characteristics (SmPC) notes that gut reactions mostly occurred during dose escalation and decreased over time.^[3]

Two things follow from that. First, a person's worst weeks are usually early, not late. Second, every step up in dose can bring the symptoms back for a while. Slowed gastric emptying, meaning food leaving the stomach more slowly, is part of why people feel full, bloated or sick.

What the trials did about it

The Phase 2 trial tested two different starting points for the highest dose and found that the lower starting point reduced gut side effects.^[2] The Phase 3 trials then used stepwise escalation: everyone started low and was moved up in stages, under the eye of a trial clinician.^[1] That is a design fact about the trials, not a template. A clinician in a trial would adjust treatment; outside a trial there is no clinician and no known dose.

When gut symptoms become dangerous

Nausea on its own is unpleasant. Persistent vomiting or diarrhoea is different, because you lose water and salts faster than you can replace them. Both the Wegovy and Mounjaro SmPCs warn that gut side effects can cause dehydration, which can in turn lead to a deterioration in kidney function, including acute kidney failure.^[7][3] The same class warning is the sensible working assumption for retatrutide.

Two Australian cases in 2026 show what that looks like when the product is unlicensed and the dose unknown. A man in his 40s developed major kidney injury from extreme dehydration after having diarrhoea about 40 times a day on a product labelled retatrutide.^[8] A gastroenterologist in Melbourne described a young man losing an estimated eight litres of fluid a day to watery diarrhoea and needing intravenous fluids in hospital; the same report covered a vial that contained nearly double the amount of retatrutide printed on its label.^[9] More on that on the liver and kidney page.

The NHS lists the signs of dehydration as thirst, headache, feeling light-headed or dizzy, dark yellow strong-smelling urine, passing urine less often, tiredness and a dry mouth.^[10] It advises an urgent GP appointment or NHS 111 if you feel unusually tired, feel dizzy on standing and it does not pass, or have dark urine or are passing less than normal.^[10]

Constipation and reflux

Constipation is easy to overlook next to nausea, but in TRIUMPH-1 it affected around a quarter of people on every retatrutide dose, versus one in nine on placebo.^[1] Slower gut movement and eating much less both contribute. The NHS constipation page covers fibre, fluids and activity, and says to see a GP if it is not improving or you have blood in your stool, unexplained weight loss or constant tiredness.^[11]

Acid reflux (heartburn) is a recognised side effect of this drug class: gastro-oesophageal reflux disease appears in both the Wegovy and Mounjaro SmPCs.^[7][3] Lilly's topline retatrutide announcements did not give a reflux figure, so we do not know how retatrutide compares.

Anti-sickness medicines

Trial doctors could prescribe anti-sickness medicines. We do not recommend any particular one, and neither should anyone online. One reason is specific: in the Phase 2 trial the single severe heart-rhythm event, a prolonged QT interval, occurred in a participant who was also taking ondansetron, a common anti-sickness drug that itself prolongs the QT interval.^[2] Whether an anti-sickness medicine is safe for you depends on your heart, your other medicines and what you have actually taken. That is a decision for a GP, who can only make it if you tell them what you have used. See talking to your GP and heart rate and rhythm.

Trial product versus what is sold online

Everything above comes from trials of a pharmaceutical-grade product at a known dose. Independent testing of vials sold as retatrutide has found strengths far above and below the label.^[9] A vial that is double strength does not just double the weight loss; it can produce gut effects, and fluid loss, beyond anything the trials recorded. Unlicensed products also carry risks the trials could not measure at all: contamination, infection and unknown extra ingredients. See what is actually in the vials.